Cargando…

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue

Idiopathic pulmonary fibrosis (IPF) is a progressive and fibrosing lung disease with a poor prognosis. Between 60% and 70% of IPF patients die of IPF; the remaining causes of death may be due to comorbidities occurring in this ageing population. Interest in the role played by comorbidities in IPF ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caminati, Antonella, Lonati, Chiara, Cassandro, Roberto, Elia, Davide, Pelosi, Giuseppe, Torre, Olga, Zompatori, Maurizio, Uslenghi, Elisabetta, Harari, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488913/ https://www.ncbi.nlm.nih.gov/pubmed/31578211 http://dx.doi.org/10.1183/16000617.0044-2019

Ejemplares similares

Pulmonary hypertension and chronic lung disease: where are we headed?
por: Elia, Davide, et al.
Publicado: (2019)

Severe idiopathic pulmonary fibrosis: what can be done?
por: Caminati, Antonella, et al.
Publicado: (2017)

Ultra-rare cystic disease
por: Elia, Davide, et al.
Publicado: (2020)

Prognostic role of CHA(2)DS(2)-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation
por: Sonaglioni, Andrea, et al.
Publicado: (2023)

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure
por: Harari, Sergio, et al.
Publicado: (2019)

Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
por: Harari, Sergio, et al.
Publicado: (2015)

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
por: Torre, Olga, et al.
Publicado: (2017)

Prognostic value of radiological index and clinical data in patients with COVID-19 infection
por: Elia, Davide, et al.
Publicado: (2022)

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy
por: Harari, Sergio, et al.
Publicado: (2016)

Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period
por: Sonaglioni, Andrea, et al.
Publicado: (2022)

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation
por: Caminati, Antonella, et al.
Publicado: (2015)

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment
por: Caminati, Antonella, et al.
Publicado: (2023)

Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions
por: Faverio, Paola, et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
por: van Cleemput, Johan, et al.
Publicado: (2018)

Chest-CT mimics of COVID-19 pneumonia—a review article
por: Carlicchi, Eleonora, et al.
Publicado: (2021)

Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015)

Comorbidities and Complications in Idiopathic Pulmonary Fibrosis
por: Cano-Jiménez, Esteban, et al.
Publicado: (2018)

The Octopus Sign—A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis
por: Poellinger, Alexander, et al.
Publicado: (2022)

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
por: Ferrara, Giovanni, et al.
Publicado: (2018)

Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
por: Taha, Nada, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night
por: Schiza, Sophia, et al.
Publicado: (2015)

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
por: Kreuter, Michael, et al.
Publicado: (2016)

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
por: Oldham, Justin M., et al.
Publicado: (2017)

Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
por: Keow, Jonathan, et al.
Publicado: (2022)

Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
por: Millan-Billi, Paloma, et al.
Publicado: (2018)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2020)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study
por: Faverio, Paola, et al.
Publicado: (2022)

Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
por: Manzetti, Gian Marco, et al.
Publicado: (2021)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
por: Alfaro, Tiago M., et al.
Publicado: (2020)

Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
por: Lee, Jang Ho, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
por: Balestro, Elisabetta, et al.
Publicado: (2019)

Progression of renal fibrosis: the underestimated role of endothelial alterations
por: Guerrot, Dominique, et al.
Publicado: (2012)

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
por: Jovanovic, Dragana M., et al.
Publicado: (2022)

Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
por: Faverio, Paola, et al.
Publicado: (2022)

Effect of malnutrition in infants with cystic fibrosis in India: An underestimated danger
por: Thomas, Leenath, et al.
Publicado: (2021)

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_18p2cflocpkh9jee4j43nrccet